9:22 AM
Leo Group India
| ||
| FDI in pharma: Ministerial group may take final call tomorrow Economic Times NEW DELHI: An inter-ministerial group is expected to take a final call tomorrow on issues related with FDI in pharmaceutical sector in the wake of the Prime Minister's Office seeking a status report on the policy. While the the Department of Economic Affairs ... See all stories on this topic » | ||
| Retain 49% cap on FDI in pharma through automatic route: panel The Hindu The inter-Ministerial Expert Group formed by the Finance Ministry to decide foreign direct Investment (FDI) in pharmaceutical sector will meet here on Tuesday to give a final touch to its suggestions which include government role in guiding foreign direct ... See all stories on this topic » | ||
| Sandoz completes acquisition of Fougera Pharmaceuticals, positioning Sandoz ... MarketWatch (press release) Fougera Pharmaceuticals currently employs approximately 700 people across its US sites. It operates two main businesses: Fougera, a leading player in the US dermatology generics sector with 45 products and more than 200 SKUs, and PharmaDerm, ... See all stories on this topic » | ||
| Are the following doing enough to help solve the problem, or are they not doing ... Washington Post This Washington Post-Kaiser Family Foundation poll was conducted by telephone June 11 to 24, 2012, among a random national sample of 1524 adults ages 18 and older. Interviews were conducted on conventional and cellular telephones, and carried out ... See all stories on this topic » | ||
| Week Of July 23rd Comprised Of Huge Pharmaceutical Catalysts Seeking Alpha The euphoria around Arena Pharmaceuticals' (ARNA) and Vivus' (VVUS) obesity drug approvals reached feverish levels with huge returns possible for those making early entries into the common stocks. For example, closing prices for ARNA and VVUS on ... See all stories on this topic » | ||
| Pharmaceutical Stock News: ScripsAmerica (OTCBB:SCRC) Begins Trading on ... InvestorIdeas.com (press release) ScripsAmerica is a national low-cost supplier and distributor of generic Rx, branded Rx, OTC, nutraceuticals, and oral delivery OTC pharmaceuticals. The company distributes these products through mass merchants, super markets, chain drug stores, ... See all stories on this topic » | ||
| Onyx gains FDA approval for Kyprolis for injection Pharmaceutical Business Review Onyx Pharmaceuticals, a licensee of Ligand Pharmaceuticals, has gained FDA approval for Kyprolis (carfilzomib) for injection. Kyprolis is a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior ... See all stories on this topic » | ||
| Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth ... MarketWatch (press release) MOUNTAIN VIEW, Calif., July 23, 2012 /PRNewswire via COMTEX/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today that it has obtained a committed equity financing facility under which it may sell up to $20 million of its registered common ... See all stories on this topic » | ||
| FDA approves blood cancer drug Drug Store News based Onyx Pharmaceuticals' Kyprolis (carfilzomib). The drug is designed for patients with the disease who have received at least two prior therapies, including Takeda Pharmaceutical Co.'s Velcade (bortezomib) and an immunomodulatory therapy. Multiple ... See all stories on this topic » | ||
|
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment